Curriculum vitea

Dimiter Dimitrov MD, PhD

Systems Biology, Chalmers Technical University, Sweden
Specialty of Endocrinology, University Hospital Varna, Bulgaria

2002 Human Nutrition, Department of Human Nutrition, Denmark
Ph.D. Endocrinology and Metabolic diseases, Medical University Varna, Bulgaria
Specialty of Internal Diseases, University Hospital Varna, Bulgaria
Medical Doctor (MD), Medical University Varna, Bulgaria


Assistant Professor, Department of Biochemistry, Molecular Medicine and Nutrigenomics,
Medical University Varna, Bulgaria
2001- 2006 Research Associate, Department of Endocrinology, Medical University Varna, Bulgaria

2007- 2009 Senior Research Physician, Obesity Expert,
Early Clinical Development, AstraZeneca
R&D, Sweden
2002 -2007 ICH/GCP Clinical Trails Phase II-IV,
University Hospital Varna, Bulgaria
EASO SCOPE Expert: European Obesity Association Recognition as National
Travel grants: ISE (International Society of Endocrinology) 2004; EAS (European
Atherosclerosis Society) 2005; EASO (European Association for the Study of Obesity) 2005 • Best Scientific Yearly Achievement – 2007: Municipality of Varna, Bulgaria

Publications in International Scientific Journals
Dimitrov DV. “The Human Gutome: Nutrigenomics of Host – Microbiome Interactions” Omics: Journal of Integrative Biology, 2011 Dimitrov DV.Current healthcare in Bulgaria: time for predictive diagnostics
and preventive medicineEPMA Journal, 2010, DOI 10.1007/s13167-010-
Dimitrov D. et al. “Screening for diabetic foot and osteoporosis in Bulgaria” The Diabetic Foot Journal Vol 10 No 1 2007 Dimitrov D. et al. “Nutrigenomics: DNA – based diet plan” Biomedical Reviews, 2007 Dimitrov D. et al. “Homo Obesus: A metabotrophin-deficient species. pharmacology and nutrition insight”, Curr Pharm Des, 2007 Dimitrov D “Stress, dietary habits and Metabolic syndrome” – Biological Psychiatry and Psychopharmacology, vol.2, 2006 Dimitrov D. et al. “Effect of Orlistat on plasma leptin levels and risk factors for the metabolic syndrome”, Metabolic Syndrome and Related Disorders Journal, 2005, 3; 2, pp. 149-156 Publications in Bulgarian Scientific Journals
• D.Dimitrov “Role of oxidative stress in the pathogenesis of diabetes mellitus and its complications “ -review, Endocrine Diseases, 1998, 4, 3-12 • D.Dimitrov et al. “Leptin and cardiovascular risk factors among overweight diabetics”, Bulgarian Endocrinology, 2000, 1 ,6-11 • D.Dimitrov, L.Koeva “Leptin – the voice of adipose tissue” – review, Bulgarian • D.Dimitrov, L.Koeva, H.Bochchelian “Effect of α-lipoic acid on EMG in diabetic patients”, Modern Medicine, 2001, 1, 3-11 • D.Dimitrov, L.Koeva, T.Rousseva “OBES – Orlistat Bulgarian Estimation Study“, Bulgarian Endocrinology 2002, 2, 7-11
Presentations in Conferences
Euroconference on Obesity, 25-27.11.1999, Paris, France: D.Dimitrov, L.Koeva “Plasma leptin concentrations – effect of gender and menopause “ European Congress on Obesity, Antwerp, Belgium 24-27.05.2000: D.Dimitrov et al. “Leptin and cardiovascular risk factors among overweight diabetics” abstract book “International Journal of Obesity“ 2000, vol.24, suppl.1 (The last work was accepted also for presentation at the International Congress on Obesity in Essen, Germany (March 2000) and at the International Symposium of Atherosclerosis in Stockholm, Sweden (June 2000). 5th European Congress of Endocrinology, Turin, Italy, June 2001: D.Dimitrov, L.Koeva, H.Bohchelian “ Leptin and bone mineral density in obesity “ 72th European Atherosclerosis Congress, May 2001, Glasgow, UK: D.Dimitrov, L.Koeva, T.Kovatcheva, T.Rousseva “ Effect of orlistat on insulin resistance, cardiovascular risk factors and plasma leptin levels in obese type 2 diabetic subjects “ VIIIth International Symposium on Insulin Receptors and Insulin Action, Geneva, Switzerland, May 2001: D.Dimitrov, L.Koeva, T.Rousseva “ Leptin and the Insulin Resistance Syndrome “ 11th European Congress on Obesity, Viena, Austria, May 2001: D.Dimitrov, L.Koeva, T.Kovatcheva, T.Rousseva “ Effect of orlistat on insulin resistance, cardiovascular risk factors and plasma leptin levels in obese type 2 diabetic subjects” 10th Balkan Congress of Endocrinology, 1-3 October , Istanbul, Turkey: D.Dimitrov, L.Koeva “ Is leptin a risk marker for coronary heart disease” 10th World Congress of Menopause, Berlin 2002: D.Dimitrov, L.Koeva “Prevalence of hyperleptinemia among postmenopausal obese women” 9th International Congress of Obesity, Brazil, August 2002: D.Dimitrov, L.Koeva “
Gastrointestinal side effects of Orlistat can be reduced with Ispanghula Husk (Mucofalk)” 13th European Congress on Obesity, 26 – 29 May, 2004, Prague, Czech Republic: Birgitte Sloth, Inger Krog-Mikkelsen, Dimiter Dimitrov, Anne Flint, Inge Tetens, Inger Björck, Sophie Vinoy, Helena Elmståhl, Arne Astrup, Vincent Lang, Anne Raben. Effect of low vs high glycemic index diets on postprandial appetite and energy expenditure.” Albena International Symposium, Varna Bulgaria (Satellite Symposium of European Congress of Obesity, Prague), June 2004: D. Dimitrov “Adipocytokines and metabolic syndrome” International Congress of Endocrinology, Lisbon, Portugal 2004: D. Dimitrov, L. Koeva “Combined therapy for morbid obesity –a case report”, 4th Nordic Obesity Meeting, October 22-23 2004, Copenhagen: Inger Krog-Mikkelsen, Birgitte Sloth, Dimiter Dimitrov, Jens Juul Holst, Anne Flint, Inge Tetens, Inger Björck, Helena Elmståhl, Arne Astrup, Anne Raben. Effects of low vs. high glycemic index diets on appetite and energy expenditure.” 1st International Congress “Prediabetes and the Metabolic syndrome”, April 2005, Berlin, Germany: D. Dimitrov, L. Koeva. Prevalence of metabolic syndrome among type 2 diabetics” 4th International Symposium on Obesity and Hypertension, ISOH`05, Berlin, Germany, 2005: D. Dimitrov “Hyperleptinemia and hypertension in metabolic syndrome subjects” European Congress of Endocrinology, 2006, Glasgow, UK: D. Dimitrov, L. Koeva “Dietary supplements for stress and obesity co-morbidities reduction” XIV International Symposium on Atherosclerosis, June 2006, Rome, Italy, D. Dimitrov “ Effect of omega 3 fatty acids on risk factors for the Metabolic syndrome” 10th International Congress on Obesity, Sydney, Australia 2006 D. Dimitrov “Stress and obesity co-morbidities reduction through diet”


Management of acute coronary syndrome

ACUTE CORONARY SYNDROME MANAGEMENT PROCEDURE AND CHECK-LIST QUALITY ASSURANCE PROGRAMME (UNDER HNPSP) DIRECTORATE GENERAL OF HEALTH SERVICES MOHAKHALI, DHAKA-1212 ANTIDOTE • Tranexamic Acid 10mg/kg body weight by slow I/V injection TABLE OF CONTENTS (1mL/min); can be repeated after 6-8 hours. • Administer cryoprecipitate or fresh blood if severe bleeding

Day, 1xth april 2010

October 3rd 2012 The FTSE 100 is expected to make a lacklustre start to the session, after disappointing data from China. Non-manufacturing PMI fell to 53.7 in September from 56.3 in August. Final services PMI figures are due later this morning from the UK and the eurozone, with the UK reading forecast to be revised down to 53 from 53.7. On the corporate front, supermarket giant TESCO

Copyright © 2010-2014 Medical Articles